JP2014508174A5 - - Google Patents

Download PDF

Info

Publication number
JP2014508174A5
JP2014508174A5 JP2013558168A JP2013558168A JP2014508174A5 JP 2014508174 A5 JP2014508174 A5 JP 2014508174A5 JP 2013558168 A JP2013558168 A JP 2013558168A JP 2013558168 A JP2013558168 A JP 2013558168A JP 2014508174 A5 JP2014508174 A5 JP 2014508174A5
Authority
JP
Japan
Prior art keywords
dose
dose adjustment
week
interferon
adjustment package
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013558168A
Other languages
English (en)
Japanese (ja)
Other versions
JP6279905B2 (ja
JP2014508174A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/029201 external-priority patent/WO2012125809A1/en
Publication of JP2014508174A publication Critical patent/JP2014508174A/ja
Publication of JP2014508174A5 publication Critical patent/JP2014508174A5/ja
Application granted granted Critical
Publication of JP6279905B2 publication Critical patent/JP6279905B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013558168A 2011-03-15 2012-03-15 速い用量調節の漸増投与レジメンを用いた、インターフェロンの筋肉内投与に伴うインフルエンザ様症状を軽減するための方法 Active JP6279905B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161452807P 2011-03-15 2011-03-15
US61/452,807 2011-03-15
US201161476930P 2011-04-19 2011-04-19
US61/476,930 2011-04-19
PCT/US2012/029201 WO2012125809A1 (en) 2011-03-15 2012-03-15 Method for reducing flu-like symptoms associated with intramuscular administration of interferon using a fast titration escalating dosing regimen

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017170640A Division JP6522069B2 (ja) 2011-03-15 2017-09-05 速い用量調節の漸増投与レジメンを用いた、インターフェロンの筋肉内投与に伴うインフルエンザ様症状を軽減するための方法

Publications (3)

Publication Number Publication Date
JP2014508174A JP2014508174A (ja) 2014-04-03
JP2014508174A5 true JP2014508174A5 (enExample) 2015-04-16
JP6279905B2 JP6279905B2 (ja) 2018-02-14

Family

ID=46045072

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013558168A Active JP6279905B2 (ja) 2011-03-15 2012-03-15 速い用量調節の漸増投与レジメンを用いた、インターフェロンの筋肉内投与に伴うインフルエンザ様症状を軽減するための方法
JP2017170640A Active JP6522069B2 (ja) 2011-03-15 2017-09-05 速い用量調節の漸増投与レジメンを用いた、インターフェロンの筋肉内投与に伴うインフルエンザ様症状を軽減するための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017170640A Active JP6522069B2 (ja) 2011-03-15 2017-09-05 速い用量調節の漸増投与レジメンを用いた、インターフェロンの筋肉内投与に伴うインフルエンザ様症状を軽減するための方法

Country Status (25)

Country Link
US (6) US9198955B2 (enExample)
EP (1) EP2686002B1 (enExample)
JP (2) JP6279905B2 (enExample)
KR (1) KR102050339B1 (enExample)
CN (1) CN103702680A (enExample)
AU (1) AU2012229104B2 (enExample)
BR (1) BR112013023609A8 (enExample)
CA (1) CA2846786C (enExample)
CY (1) CY1120176T1 (enExample)
DK (1) DK2686002T3 (enExample)
EA (1) EA028448B1 (enExample)
ES (1) ES2666850T3 (enExample)
HR (1) HRP20180621T1 (enExample)
HU (1) HUE036931T2 (enExample)
IL (1) IL228425A (enExample)
LT (1) LT2686002T (enExample)
MX (1) MX359947B (enExample)
PL (1) PL2686002T3 (enExample)
PT (1) PT2686002T (enExample)
RS (1) RS57175B1 (enExample)
SG (1) SG193446A1 (enExample)
SI (1) SI2686002T1 (enExample)
SM (1) SMT201800221T1 (enExample)
WO (1) WO2012125809A1 (enExample)
ZA (1) ZA201306933B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2846786C (en) * 2011-03-15 2022-05-17 Biogen Idec Inc. Method for reducing flu-like symptoms associated with intramuscular administration of interferon using a fast titration escalating dosing regimen
EP3092305B1 (en) 2014-01-09 2023-08-02 Kyushu University, National University Corporation Method of producing microglial cells
WO2018056584A1 (ko) 2016-09-21 2018-03-29 삼성전자 주식회사 피부 상태 측정 방법 및 이를 위한 전자 장치
WO2022069250A1 (en) * 2020-09-30 2022-04-07 Koninklijke Philips N.V. Methods and systems for performing dose titration

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4456748A (en) 1981-02-23 1984-06-26 Genentech, Inc. Hybrid human leukocyte interferons
WO1982002715A1 (fr) 1981-02-04 1982-08-19 Sugano Haruo Gene d'interferon (beta)humain
US4695543A (en) 1982-03-23 1987-09-22 Bristol-Myers Company Alpha Interferon GX-1
CA1302320C (en) 1984-06-11 1992-06-02 Hideo Niwa Expression of human cromosomal interferon-_ in animal cells
US5231176A (en) 1984-08-27 1993-07-27 Genentech, Inc. Distinct family DNA encoding of human leukocyte interferons
FI90990C (fi) 1984-12-18 1994-04-25 Boehringer Ingelheim Int Rekombinantti-DNA-molekyyli, transformoitu isäntäorganismi ja menetelmä interferonin valmistamiseksi
ATE78262T1 (de) 1985-06-11 1992-08-15 Ciba Geigy Ag Hybrid-interferone.
US5641656A (en) 1993-10-22 1997-06-24 University Of Connecticut Nucleic acids encoding avian interferon (IFN) proteins and recombinant methods using them
DE69729880T3 (de) * 1996-12-24 2012-05-10 Biogen Idec Ma Inc. Stabile flüssige interferon-zubereitungen
JP2001104482A (ja) * 1999-10-07 2001-04-17 Terumo Corp 2室型プレフィルドシリンジ
US8932265B2 (en) * 2003-01-30 2015-01-13 Becton, Dickinson And Company Holder with safety shield for a drug delivery device
US7731948B2 (en) * 2004-06-01 2010-06-08 Ares Trading S.A. Stabilized interferon liquid formulations
US20060089593A1 (en) * 2004-10-26 2006-04-27 Sergio Landau Needle-free injection device for individual users
EP1923085A1 (en) * 2006-11-17 2008-05-21 Sanofi-Aventis Deutschland GmbH Dosing and drive mechanism for drug delivery device
US8071544B2 (en) * 2006-12-18 2011-12-06 Althea Technologies, Inc. Crystallized recombinant human growth factor formulations
US9044378B2 (en) * 2007-05-31 2015-06-02 Safety Syringes, Inc. Anti-needle stick safety device or system for use with drugs requiring reconstitution
JP5549048B2 (ja) * 2007-08-16 2014-07-16 味の素株式会社 薬剤バイアルとプレフィルドシリンジの接続構造
MX2011013722A (es) * 2009-06-18 2012-05-08 Wyeth Llc Formulaciones liofilizadas para inmunofarmaceuticos modulares pequeños.
CA2846786C (en) * 2011-03-15 2022-05-17 Biogen Idec Inc. Method for reducing flu-like symptoms associated with intramuscular administration of interferon using a fast titration escalating dosing regimen

Similar Documents

Publication Publication Date Title
Zhang et al. Just how prevalent are peptide therapeutic products? A critical review
TWI705820B (zh) Gip/glp1促效劑組合物
KR102711661B1 (ko) 구역과 구토를 치료하기 위한 아미설프리드 및 추가의 구토 방지제의 병용
Middleton et al. Complications of injectable testosterone undecanoate in routine clinical practice
JP2015187125A5 (enExample)
HRP20170056T2 (hr) Terapija male učestalosti glatiramer acetatom
JP2013509435A5 (enExample)
IL309340A (en) Dosing regimen for missing doses of paliperidone long-acting injectable esters
JP2018514534A5 (enExample)
NZ599558A (en) Dosing regimen associated with long-acting injectable paliperidone esters
JP2016204396A5 (enExample)
RU2008138381A (ru) Режимы дозирования адреналина
JP2018510894A5 (enExample)
Cutolo et al. Efficacy of the switch to modified-release prednisone in rheumatoid arthritis patients treated with standard glucocorticoids
RU2015152860A (ru) Режим введения и составы для аденовирусов типа в
JP2016526039A5 (enExample)
Tan et al. The next generation of antiemetics for the management of postoperative nausea and vomiting
HRP20201388T1 (hr) Režimi i postupci liječenja multiple skleroze uporabom ofatumumaba
JP2016534996A5 (enExample)
Gopalakrishna et al. Long-acting injectable aripiprazole: how might it fit in our tool box?
JP2016515137A5 (enExample)
HRP20240812T1 (hr) Oblici doziranja i terapijska primjena l-4-klorokinurenina
JP2014520874A5 (enExample)
MX2018005298A (es) Regimen de dosificacion para un inhibidor de fosfatidilinositol 3-quinasa.
SI2686002T1 (en) A method for reducing influenza-like symptoms associated with intramuscular delivery of interferon by the rapid titration-enhancing regimen